Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
after the ASCO 2023 Poster reveal, BioRay ditched them (badly disguised as 'regains world-wide rights') and they are not giving them 2.5M for these poor results, not wonder they did not develop it themselves; they already knew it was not effective. Begs the question.... where on Earth will they get money to continue? Perhaps that letter to shareholders about needing to raise money (18M) means an offering soon = dilution. IMHO.
https://finance.yahoo.com/news/nascent-biotech-regains-worldwide-rights-214500439.html
https://www.nascentbiotech.com/a-letter-to-nascent-biotech-shareholders-may-1-2023/
ASCO 2023 Dr. Bosch Video link
$NWBO Dr. Bosch ASCO 2023 Video.https://t.co/tbWbMrSHNX
— LearningEveryTrade 🚀📈💰 (@EveryTrade) June 7, 2023
LC, what is INDIGO OS ?? Since that's the Gold Standard.
ZZZZZZZZZZZZZZZZZZ...
(your response, I'll do it for you... "ZZZZZZZZZZZ like the stock performance") LOL...
RD, of course, there is literally zero money to be made at these volumes, so, only one option remains... coded messaging aka marching orders for the troops. IMHO.
Pre-Market 11,000vol; 100@ 08:00:02 am
1500@ 08:00:02 am
9400@ 08:08:00 am
NWBO seems to trade pre-market all the time, low volumes of course. I've never really know other OTC to do that, since they are not supposed to.
Well see how today goes after the good Industry Presentation versus influx of negative comments.
10,000 Premarket just hit. hmm.
+25% seems to be dis-liked by the algos...I think any big run-ups have stopped there historically, from my simple brain noticing.. not backed by charts, just casual observation.
Novocure has never been involved in a drug approval either. Fact, not a guess.
dstock, I disagree on one statement.
dstock, yeah, 6 months out is pretty crazy. I guess to be across from Merck, ya gotta be early. lol.
SITC Nov 1-5, 2023 Booth 609
$NWBO SITC 2023 Booth #609 11/1-5/2023 Across from Merck, Dr. Prins Co-Chairs a session- Not much else yet. https://t.co/MfgiolL3Wd #DCVAX #Murcidencel pic.twitter.com/yNuOrp5WvR
— LearningEveryTrade 🚀📈💰 (@EveryTrade) April 20, 2023
Pattyloco, could it be sealioning??
The lack of PR's might be a result of the disgusting practice of 'short the news'. The good old days of 'sell' the news was fine, they were your shares you no longer wanted to be long on... versus the selling of long-intended shares. This is a problem.
Dr. Bosch, ASCO 2023 IET.
$NWBO #ASCO23 Dr. Marnix Bosch at Industry Experts Theater introducing experts to DCVax for Solid Tumors. June 3, 2023. The IET's are more of a corporate presentation, hence not sponsored by ASCO. pic.twitter.com/BjVx7bqA0Z
— LearningEveryTrade 🚀📈💰 (@EveryTrade) April 9, 2023
The Wes call, without rewatching it, I can paraphrase this... 'if we can get this case past 1st base, we'll see the mother lode of all short selling.'
Now, since he's a lawyer, he said 'case'. Of GTII/MMTLP/GNS, the only one with a "case" at the time was NWBO....so, there's that.
Also, Mother Lode, refers to "source", not amount... so, there's that.
I think the 'gifting' Dr Boynton did makes these shares "open" to trade anytime, without board approval or paperwork, by the new owner, right? That is certainly something to wonder about.
I would love to see Dr. Bosch do the same gifting soon... and especially would love to see LP do it, but that would be too huge of a signal.
How can someone "fat finger" OTC pre-market volume of 1.75K, not supposed to trade OTC Pre/Post? Oh Wait, market makers can... the more I look, the more 'code-like' the pre-market volume seems to actually be something beyond a conspiracy.
Happy, just like the responses to a simple posting about a company event.
Same Rode Hard and Put Away Wet responses to a post that I actually said was same as last year, as to make it not a real talking point. Another poster thinks this means a buyout. iHub is interesting for sure.
$NWBO #ASCO2023 #ASCO23 #DCVAX Appears to be similar location and size as previous years. https://t.co/rhyaMXmmnd pic.twitter.com/1kyVND5Qu6
— LearningEveryTrade 🚀📈💰 (@EveryTrade) April 6, 2023
ASCO 2023
$NWBO #ASCO2023 #ASCO23 #DCVAX Appears to be similar location and size as previous years. https://t.co/rhyaMXmmnd pic.twitter.com/1kyVND5Qu6
— LearningEveryTrade 🚀📈💰 (@EveryTrade) April 6, 2023
Bio, the only Zavocio info I have is from his Linkken in page. There are many gems of info and wild speculation points there.
https://www.linkedin.com/in/george-zavoico-8441262/
Zavocio has been helping NYAS for 30 years, volunteering and being a steering committee member. So, his being there is not new, but being an apparent employee of NWBO, yet still consultant for CUE Bio, is Very interesting for sure.
The plot is thickening.
Can't wait for the un-announced slot titles and speakers. We should know soon.
Flipper GMP was there 3/20
$NWBO Mike Scott of Advent Bioservices UK gets a Halo for major career accomplishments. GMP and MIA https://t.co/ehIB5P0Lcwhttps://t.co/mTCQ71s9yd pic.twitter.com/bYFkd400Hz
— LearningEveryTrade 🚀📈💰 (@EveryTrade) March 21, 2023
re:
JD: You should return the favor
43% Survival Extension in Multikine IT-MATTERS study !!
https://finance.yahoo.com/news/cel-sci-multikine-phase-3-140000412.html
“Assessment of Treatment Response to Dendritic Cell Vaccine in Patients with Glioblastoma using a Multiparametric MRI-Based Prediction Model”@JNeurooncol $nwbo #dcvaxhttps://t.co/LeDZVxcIOK pic.twitter.com/oLdc0uSW1J
— Ida Bogac (@albtur_mnymkrs) February 20, 2023
re:
CaptO, I can't really guess on they Mav meant, however, I personally just see people who's goal is pure, getting this to be widely available to patients, across the globe.
When I watch really old video clips, sometimes I cringe... as they had no idea what a David to Goliath they were. However, we know who wins that one in the end.
When I watch more recent clips/ASM audio, I can hear the experience they have gained from the battles. Learning from mistakes and successes alike. Motivations still seem pure and honest. I consider them all very likable, genuine people.
For me, the people matter. For some, it's greed and high-fiving each other when they kill a company.
Do you have link for presentation? So far, I have only found a NWBio employee/consultant as a session moderator, session chairperson and on the SOC.
Kudos to Muskaan Aggarwal! With an interest in immunology + oncology, she summarizes the science behind the Phase 3 trial, led by Dr. Linda Liau, @UCLANsgy, @JAMAOnc, "Dendritic Cell Vaccines: A New Frontier of Treatment for #GBM" @PennNSG #immunotherapy https://t.co/scbkMDjKnN
— Steven Brem (@StevenBremMD) January 29, 2023
NYAS 2023 NWBO SOC member
$NWBO NYAS May 3-5, 2023 Frontiers in Cancer Immunotherapy Scientific Organizing Committee. Dr. George Zavoico from Northwest Biotherapeutics is on committee. Hmmm. #DCVAX #Murcidencel #GBM pic.twitter.com/662YVrwpt2
— LearningEveryTrade 🚀📈💰 (@EveryTrade) January 27, 2023
Youtuber video on lawsuit.
$NWBO A guy who sounds cool talking references the NWBio lawsuit. https://t.co/MoyJBurcLC
— LearningEveryTrade 🚀📈💰 (@EveryTrade) January 25, 2023
They admit their customers spoofed, not them as market makers. Kinda like Napster, the customer was the thief, not the platform...alas, the Govt did shut that down.... fingers and toes crossed.
Lots of "CEO", "One CEO to another CEO". If your a "CEO" you know... etc... I love what they are doing, added 30% to my NWBO with Wed to Friday profit. But that Roger is hilarious with his "CEO" word count on videos.
Agree and solid advice. I took out my Wed(.52) original+20% and now sit with house money.
I think the 329% borrow fee is interesting...clearly, hard to borrow with a -325% rebate.
https://chartexchange.com/symbol/nyseamerican-gns/borrow-fee/
Here ya go, https://www.courtlistener.com/docket/66579590/northwest-biotherapeutics-inc-v-canaccord-genuity-llc/
Most companies don't discuss pending litigation.